The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Cardlytics Inc shares valued at $86,924 were sold by Gupta Amit on Oct 24 ’24. At $3.85 per share, Gupta Amit sold 22,607 shares. The insider’s holdings dropped to 178,519 shares worth approximately $0.93 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Gupta Amit purchased 22,607 shares, netting a total of over 86,919 in proceeds.
Before that, DeSieno Alexis had sold 7,487 shares from its account. In a trade valued at $23,097, the Chief Financial Officer traded Cardlytics Inc shares for $3.08 each. Upon closing the transaction, the insider’s holdings decreased to 7,487 shares, worth approximately $0.51 million.
As published in their initiating research note from Evercore ISI on October 11, 2024, Cardlytics Inc [CDLX] has been an In-line and the price target has been revised to $4. Analysts at Northland Capital downgraded the stock from ‘”an Outperform”‘ to ‘”a Market perform”‘ outlook in a report released in mid August. As of August 15, 2024, BofA Securities has decreased its “Neutral” rating to a “an Underperform” for CDLX. Earlier on August 08, 2024, Needham downgraded its rating. Their new recommendation was “a Hold” for CDLX stock which previously was a “a Buy”.
Analyzing CDLX Stock Performance
During the last five days, there has been a surge of approximately 25.85%. Over the course of the year, Cardlytics Inc shares have dropped approximately -43.43%. Shares of the company reached a 52-week high of $20.52 on 03/25/24 and a 52-week low of $2.89 on 08/08/24. A 50-day SMA is recorded $3.68, while a 200-day SMA reached $7.75. Nevertheless, trading volume fell to 2.32 million shares from 1.07 million shares the previous day.
Support And Resistance Levels for Cardlytics Inc (CDLX)
According to the 24-hour chart, there is a support level at 4.87, which, if violated, would cause prices to drop to 4.53. In the upper region, resistance lies at 5.40. The next price resistance is at 5.59. RSI (Relative Strength Index) is 77.83 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.54, which suggests the price will decrease in the coming days. Percent R is at 2.24%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
